novo nordisk glp-1 drugs EMA will monitor suicide risk in Nordisk's products Novo Nordisk's weight-loss pill wins
Description
CBS News' Dr
DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006
Among the numerous metabolic effects of GLP-1 are the glucose-dependent stimulation of insulin secretion, decrease of gastric emptying, inhibition of ...
Increasing use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) raises concern for interactions with warfarin
Diabetic peripheral neuropathy (DPN) is one of the complications of diabetes...
Quality Assurance & Verification
